Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region
The global venom-based drugs market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases, and rise in initiatives by government and private organizations, which are curbing the growth of the market. Venom is a compound which is secreted by an animal. It is a poisonous compound which intended to harm or disable their prey or enemy. When venom is produced through organisms, it includes variety of bioactive components which produce toxic effects. Only those active components of these venoms are isolated, purified, and screened which may have desirable therapeutic properties. The other factors supporting the market’s growth are, the extensive research and development, large number of clinical trials, increasing awareness, and government investments, large number of venomous animals, ease in approval of new venom-based drugs, and technological advancements in this field.
Increasing Use of Venom in Numerous Diseases
Venom derived drugs are very useful in treating various diseases such as cancer, heart attack, hypertension, acute coronary syndrome, and other, due to their potential therapeutic values, which propels the growth of the market. Several venom-based drugs are already in use such as captopril, integrilin, reptilase, exanta and others. Moreover, these venom-based drugs are used as diagnostic tools, cosmeceuticals and for drug discovery. For instance, in 2020, a study concluded that bee venom therapy might be useful in treating inflammatory forms of arthritis. Similarly, captopril is a type of drug used to cure high blood pressure and reduce the risk of heart failure after a heart attack. It is derived from a species of pit viper which is found in Brazil.
Technological Advancements and Rise in R&D activities
Owing to rising number of patients suffering from variety of diseases, the surge in demand for the treatment, is augmenting the growth of the market, globally. Various R&D activities are carried by researchers in order to treat these diseases using venom from various animals. The toxins from venom such as proteins, peptides, carbohydrates, and other components are important research tools. Subsequently, other reasons that make animal venoms attractive to researchers across the globe are the specialization, richness, and efficiency of the components present. Also, advancement in genomics, transcriptions and proteomics helps in study of these toxins, which further aids scientists to understand the venoms and their target. For instance, tozuleristide, a diagnostic drug obtained from the venom of the Israeli deathstalker scorpion, is now in clinical trials. An element of the venom, called chlorotoxin, binds to tumor cells. Researchers at the Fred Hutchinson Cancer Research Center re-engineered this protein and attached a fluorescent tag to it, resulting in a diagnostic tool that seeks out and illuminates tumors.
Market Segmentation
The global venom-based drugs market is segmented into animal type, source, therapeutic area, and company. Based on animal type, the market is divided into snake, spider, bee, and others. Based on source, the market is divided into whole venom, synthetic, recombinant, and others. Based on therapeutic area, the market is segmented into hypertension, cardiovascular diseases, neurological disorders, pain management & arthritis, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to extensive research and development on venom based drugs in the country.
Market Players
AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co., Inc., Pentapharm Limited Medicure Inc, Millennium Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Elan Pharmaceuticals, Inc., and Beijing Tobishi Pharmaceutical Co., Ltd. are some of the leading companies operating in the market.
Report Scope:
In this report, global venom based drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Venom Based Drugs Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Increasing Use of Venom in Numerous Diseases
Venom derived drugs are very useful in treating various diseases such as cancer, heart attack, hypertension, acute coronary syndrome, and other, due to their potential therapeutic values, which propels the growth of the market. Several venom-based drugs are already in use such as captopril, integrilin, reptilase, exanta and others. Moreover, these venom-based drugs are used as diagnostic tools, cosmeceuticals and for drug discovery. For instance, in 2020, a study concluded that bee venom therapy might be useful in treating inflammatory forms of arthritis. Similarly, captopril is a type of drug used to cure high blood pressure and reduce the risk of heart failure after a heart attack. It is derived from a species of pit viper which is found in Brazil.
Technological Advancements and Rise in R&D activities
Owing to rising number of patients suffering from variety of diseases, the surge in demand for the treatment, is augmenting the growth of the market, globally. Various R&D activities are carried by researchers in order to treat these diseases using venom from various animals. The toxins from venom such as proteins, peptides, carbohydrates, and other components are important research tools. Subsequently, other reasons that make animal venoms attractive to researchers across the globe are the specialization, richness, and efficiency of the components present. Also, advancement in genomics, transcriptions and proteomics helps in study of these toxins, which further aids scientists to understand the venoms and their target. For instance, tozuleristide, a diagnostic drug obtained from the venom of the Israeli deathstalker scorpion, is now in clinical trials. An element of the venom, called chlorotoxin, binds to tumor cells. Researchers at the Fred Hutchinson Cancer Research Center re-engineered this protein and attached a fluorescent tag to it, resulting in a diagnostic tool that seeks out and illuminates tumors.
Market Segmentation
The global venom-based drugs market is segmented into animal type, source, therapeutic area, and company. Based on animal type, the market is divided into snake, spider, bee, and others. Based on source, the market is divided into whole venom, synthetic, recombinant, and others. Based on therapeutic area, the market is segmented into hypertension, cardiovascular diseases, neurological disorders, pain management & arthritis, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to extensive research and development on venom based drugs in the country.
Market Players
AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co., Inc., Pentapharm Limited Medicure Inc, Millennium Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Elan Pharmaceuticals, Inc., and Beijing Tobishi Pharmaceutical Co., Ltd. are some of the leading companies operating in the market.
Report Scope:
In this report, global venom based drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Venom Based Drugs Market, By Animal Type:
- Snake
- Spider
- Bee
- Others
- Venom Based Drugs Market, By Source:
- Whole Venom
- Synthetic
- Recombinant
- Others
- Venom Based Drugs Market, By Therapeutic Area:
- Hypertension
- Cardiovascular Diseases
- Neurological Disorders
- Pain Management & Arthritis
- Others
- Venom Based Drugs Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in Venom Based Drugs Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL VENOM BASED DRUGS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Benefits of Using Venom Based Drugs
5.2. Commonly Used Animals for Deriving Venom Based Drugs
5.3. Demand for Venom Based Drugs, By Therapeutic Area
5.4. Barriers to Adoption of Venom Based Drugs
6. LIST OF VENOM BASED APPROVED DRUGS BY THE FDA
7. CLINICAL TRIALS ANALYSIS
8. GLOBAL VENOM BASED DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type (Snake, Spider, Bee, Others)
8.2.2. By Source (Whole Venom, Synthetic, Recombinant, Others)
8.2.3. By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others)
8.2.4. By Company (2021)
8.2.5. By Region
8.3. Market Map
9. NORTH AMERICA VENOM BASED DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type
9.2.2. By Source
9.2.3. By Therapeutic Area
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Venom Based Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Source
9.3.1.2.3. By Therapeutic Area
9.3.2. Mexico Venom Based Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Source
9.3.2.2.3. By Therapeutic Area
9.3.3. Canada Venom Based Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Source
9.3.3.2.3. By Therapeutic Area
10. EUROPE VENOM BASED DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type
10.2.2. By Source
10.2.3. By Therapeutic Area
10.2.4. By Country
10.3. Europe: Country Analysis
10.3.1. France Venom Based Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Source
10.3.1.2.3. By Therapeutic Area
10.3.2. Germany Venom Based Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Source
10.3.2.2.3. By Therapeutic Area
10.3.3. United Kingdom Venom Based Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Source
10.3.3.2.3. By Therapeutic Area
10.3.4. Italy Venom Based Drugs Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Animal Type
10.3.4.2.2. By Source
10.3.4.2.3. By Therapeutic Area
10.3.5. Spain Venom Based Drugs Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Animal Type
10.3.5.2.2. By Source
10.3.5.2.3. By Therapeutic Area
11. ASIA-PACIFIC VENOM BASED DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Animal Type
11.2.2. By Source
11.2.3. By Therapeutic Area
11.2.4. By Country
11.3. Asia-Pacific: Country Analysis
11.3.1. China Venom Based Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Animal Type
11.3.1.2.2. By Source
11.3.1.2.3. By Therapeutic Area
11.3.2. India Venom Based Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Animal Type
11.3.2.2.2. By Source
11.3.2.2.3. By Therapeutic Area
11.3.3. Japan Venom Based Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Animal Type
11.3.3.2.2. By Source
11.3.3.2.3. By Therapeutic Area
11.3.4. South Korea Venom Based Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Animal Type
11.3.4.2.2. By Source
11.3.4.2.3. By Therapeutic Area
11.3.5. Australia Venom Based Drugs Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Animal Type
11.3.5.2.2. By Source
11.3.5.2.3. By Therapeutic Area
12. SOUTH AMERICA VENOM BASED DRUGS MARKET OUTLOOK
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Animal Type
12.2.2. By Source
12.2.3. By Therapeutic Area
12.2.4. By Country
12.3. South America: Country Analysis
12.3.1. Brazil Venom Based Drugs Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Animal Type
12.3.1.2.2. By Source
12.3.1.2.3. By Therapeutic Area
12.3.2. Argentina Venom Based Drugs Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Animal Type
12.3.2.2.2. By Source
12.3.2.2.3. By Therapeutic Area
12.3.3. Colombia Venom Based Drugs Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Animal Type
12.3.3.2.2. By Source
12.3.3.2.3. By Therapeutic Area
13. MIDDLE EAST AND AFRICA VENOM BASED DRUGS MARKET OUTLOOK
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Animal Type
13.2.2. By Source
13.2.3. By Therapeutic Area
13.2.4. By Country
13.3. MEA: Country Analysis
13.3.1. South Africa Venom Based Drugs Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Animal Type
13.3.1.2.2. By Source
13.3.1.2.3. By Therapeutic Area
13.3.2. Saudi Arabia Venom Based Drugs Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Animal Type
13.3.2.2.2. By Source
13.3.2.2.3. By Therapeutic Area
13.3.3. UAE Venom Based Drugs Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Animal Type
13.3.3.2.2. By Source
13.3.3.2.3. By Therapeutic Area
14. MARKET DYNAMICS
14.1. Drivers
14.2. Challenges
15. MARKET TRENDS & DEVELOPMENTS
16. COMPETITIVE LANDSCAPE
16.1. AstraZeneca Plc.
16.2. Bristol-Myers Squibb Company
16.3. Merck & Co., Inc.
16.4. Pentapharm Limited
16.5. Medicure Inc
16.6. Millennium Pharmaceuticals, Inc.
16.7. Bausch Health Companies, Inc.
16.8. Novartis AG
16.9. Elan Pharmaceuticals, Inc.
16.10. Beijing Tobishi Pharmaceutical Co., Ltd.
17. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL VENOM BASED DRUGS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Benefits of Using Venom Based Drugs
5.2. Commonly Used Animals for Deriving Venom Based Drugs
5.3. Demand for Venom Based Drugs, By Therapeutic Area
5.4. Barriers to Adoption of Venom Based Drugs
6. LIST OF VENOM BASED APPROVED DRUGS BY THE FDA
7. CLINICAL TRIALS ANALYSIS
8. GLOBAL VENOM BASED DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type (Snake, Spider, Bee, Others)
8.2.2. By Source (Whole Venom, Synthetic, Recombinant, Others)
8.2.3. By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others)
8.2.4. By Company (2021)
8.2.5. By Region
8.3. Market Map
9. NORTH AMERICA VENOM BASED DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type
9.2.2. By Source
9.2.3. By Therapeutic Area
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Venom Based Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Source
9.3.1.2.3. By Therapeutic Area
9.3.2. Mexico Venom Based Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Source
9.3.2.2.3. By Therapeutic Area
9.3.3. Canada Venom Based Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Source
9.3.3.2.3. By Therapeutic Area
10. EUROPE VENOM BASED DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type
10.2.2. By Source
10.2.3. By Therapeutic Area
10.2.4. By Country
10.3. Europe: Country Analysis
10.3.1. France Venom Based Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Source
10.3.1.2.3. By Therapeutic Area
10.3.2. Germany Venom Based Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Source
10.3.2.2.3. By Therapeutic Area
10.3.3. United Kingdom Venom Based Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Source
10.3.3.2.3. By Therapeutic Area
10.3.4. Italy Venom Based Drugs Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Animal Type
10.3.4.2.2. By Source
10.3.4.2.3. By Therapeutic Area
10.3.5. Spain Venom Based Drugs Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Animal Type
10.3.5.2.2. By Source
10.3.5.2.3. By Therapeutic Area
11. ASIA-PACIFIC VENOM BASED DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Animal Type
11.2.2. By Source
11.2.3. By Therapeutic Area
11.2.4. By Country
11.3. Asia-Pacific: Country Analysis
11.3.1. China Venom Based Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Animal Type
11.3.1.2.2. By Source
11.3.1.2.3. By Therapeutic Area
11.3.2. India Venom Based Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Animal Type
11.3.2.2.2. By Source
11.3.2.2.3. By Therapeutic Area
11.3.3. Japan Venom Based Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Animal Type
11.3.3.2.2. By Source
11.3.3.2.3. By Therapeutic Area
11.3.4. South Korea Venom Based Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Animal Type
11.3.4.2.2. By Source
11.3.4.2.3. By Therapeutic Area
11.3.5. Australia Venom Based Drugs Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Animal Type
11.3.5.2.2. By Source
11.3.5.2.3. By Therapeutic Area
12. SOUTH AMERICA VENOM BASED DRUGS MARKET OUTLOOK
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Animal Type
12.2.2. By Source
12.2.3. By Therapeutic Area
12.2.4. By Country
12.3. South America: Country Analysis
12.3.1. Brazil Venom Based Drugs Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Animal Type
12.3.1.2.2. By Source
12.3.1.2.3. By Therapeutic Area
12.3.2. Argentina Venom Based Drugs Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Animal Type
12.3.2.2.2. By Source
12.3.2.2.3. By Therapeutic Area
12.3.3. Colombia Venom Based Drugs Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Animal Type
12.3.3.2.2. By Source
12.3.3.2.3. By Therapeutic Area
13. MIDDLE EAST AND AFRICA VENOM BASED DRUGS MARKET OUTLOOK
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Animal Type
13.2.2. By Source
13.2.3. By Therapeutic Area
13.2.4. By Country
13.3. MEA: Country Analysis
13.3.1. South Africa Venom Based Drugs Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Animal Type
13.3.1.2.2. By Source
13.3.1.2.3. By Therapeutic Area
13.3.2. Saudi Arabia Venom Based Drugs Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Animal Type
13.3.2.2.2. By Source
13.3.2.2.3. By Therapeutic Area
13.3.3. UAE Venom Based Drugs Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Animal Type
13.3.3.2.2. By Source
13.3.3.2.3. By Therapeutic Area
14. MARKET DYNAMICS
14.1. Drivers
14.2. Challenges
15. MARKET TRENDS & DEVELOPMENTS
16. COMPETITIVE LANDSCAPE
16.1. AstraZeneca Plc.
16.2. Bristol-Myers Squibb Company
16.3. Merck & Co., Inc.
16.4. Pentapharm Limited
16.5. Medicure Inc
16.6. Millennium Pharmaceuticals, Inc.
16.7. Bausch Health Companies, Inc.
16.8. Novartis AG
16.9. Elan Pharmaceuticals, Inc.
16.10. Beijing Tobishi Pharmaceutical Co., Ltd.
17. STRATEGIC RECOMMENDATIONS
